SEMA3A and breast cancer: Sema3A inhibits the migration and spreading of MDA-MB-231 breast cancer cells as well as their ability to form colonies in soft agar, and it also inhibits similarly the invasiveness of prostate cancer cells in in-vitro assays [108,122,123].